International Biotechnology Trust’s AnaptysBio ANAB Stock Holding History

International Biotechnology Trust’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-203	Closed	-$10K	–	68
2022 Q2	$10K	Sell	203 -9,797	-98%	-$217K	0.1%	74
2022 Q1	$348K	Hold	10,000	–	–	0.08%	65
2021 Q4	$348K	Hold	10,000	–	–	0.08%	68
2021 Q3	$271K	Hold	10,000	–	–	0.07%	64
2021 Q2	$259K	Hold	10,000	–	–	0.07%	65
2021 Q1	$216K	Hold	10,000	–	–	0.06%	56
2020 Q4	$215K	Hold	10,000	–	–	0.06%	51
2020 Q3	$148K	Hold	10,000	–	–	0.05%	53
2020 Q2	$227K	Hold	10,000	–	–	0.08%	52
2020 Q1	$140K	Hold	10,000	–	–	0.06%	56
2019 Q4	$163K	Hold	10,000	–	–	0.06%	63
2019 Q3	$350K	Buy	+10,000	New	+$476K	0.16%	55
2018 Q2	–	Sell	-8,500	Closed	-$885K	–	56
2018 Q1	$885K	Sell	8,500 -8,500	-50%	-$958K	0.35%	55
2017 Q4	$1.71M	Buy	+17,000	New	+$1.25M	0.6%	41
2017 Q2	–	Sell	-100,500	Closed	-$2.79M	–	61
2017 Q1	$2.79M	Buy	+100,500	New	+$2.34M	1.07%	27

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

International Biotechnology Trust's ANAB Position: Q3 2022 in Review

International Biotechnology Trust sold out of AnaptysBio (ANAB) in Q3 2022, closing a stake of 203 shares — an estimated $10K sold.

International Biotechnology Trust first reported a position in ANAB in Q1 2017 and held it in 15 quarters. The position peaked at $2.79M in Q1 2017. 114 funds tracked by Wall St. Rank hold ANAB as of Q3 2022.

International Biotechnology Trust reported no remaining AnaptysBio position as of Q3 2022 after selling out during the quarter.
International Biotechnology Trust sold 203 AnaptysBio shares in Q3 2022, an estimated $10K.
International Biotechnology Trust first reported a position in AnaptysBio in Q1 2017 and held it in 15 quarters.
International Biotechnology Trust's AnaptysBio position peaked at $2.79M in Q1 2017.
114 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2022.

Based on International Biotechnology Trust's 13F filing for Q3 2022, filed 8 Nov 2022.